Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
3
×
financing
3
×
life sciences
national blog main
venture capital
3
×
boston
drug development
fda
series a
startups
20/20 healthcare partners
abbvie
accent therapeutics
access biotechnology
access industries
aducanumab
alzheimer's disease
amblyotech
amgen ventures
amyotrophic lateral sclerosis
anemia
anthony despasqua
asklepios biopharmaceutical
atlas ventures
bioeurope
biogen
biomarin pharmaceutical
blood diseases
blood disorders
boulder/denver blog main
boulder/denver top stories
brainvectis
brian macdonald
c. greg guyer
cancer
cara therapeutics
christian angermayer
clinical trials
What
new
activity
advance
anemia
approvals
associated
bio
biogen
blood
body
carry
cells
clamped
companies
covid
delays
develop
developing
device
dialysis
disc
disease
diseases
drugs
economic
enclear
fast
fda
harmful
having
health
including
ipo
iron
isn’t
launches
lead
little
lot
lungs
Language
unset
3
×
Current search:
unset
×
" boston top stories "
×
" venture capital "
×
financing
×
@xconomy.com
4 years ago
Bio Roundup: Fast FDA Approvals, Biogen Delays, ORIC’s IPO & More
@xconomy.com
4 years ago
EnClear Therapies Nets $10M to Test Neuro Disease ‘Dialysis’ Device
@xconomy.com
4 years ago
Disc Medicine Launches With $50M to Advance New Anemia Treatments